EDIT - Editas Medicine Inc
IEX Last Trade
3.75
0.040 1.067%
Share volume: 1,135,914
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.71
0.04
1.08%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-02-22 | 2023-05-05 | 2023-08-02 | 2023-11-03 | 2024-02-28 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 580.833 M | 531.029 M | 514.321 M | 464.105 M | 541.953 M | 504.650 M | 499.153 M | 440.347 M | |
| Current Assets | 461.377 M | 426.629 M | 356.754 M | 324.458 M | 440.978 M | 358.603 M | 340.829 M | 305.555 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 8.106 M | 6.892 M | 7.335 M | 5.777 M | 6.724 M | 6.564 M | 7.531 M | 9.139 M | |
| Short Term Investments | 8.106 M | 6.892 M | 7.335 M | 5.777 M | 6.724 M | 6.564 M | 7.531 M | 9.139 M | |
| Total Receivables | 713.000 K | 120.000 K | 5.145 M | 242.000 K | 2.286 M | 2.422 M | 10.187 M | 245.000 K | |
| Current Cash | 452.558 M | 419.617 M | 344.274 M | 318.439 M | 431.968 M | 349.617 M | 323.111 M | 296.171 M | |
| Total Non-current Assets | 119.456 M | 104.400 M | 157.567 M | 139.647 M | 100.975 M | 146.047 M | 158.324 M | 134.792 M | |
| Property Plant Equipment | 16.198 M | 15.494 M | 15.569 M | 13.211 M | 12.846 M | 11.559 M | 12.032 M | 13.257 M | |
| Other Assets | 7.530 M | 7.530 M | 5.253 M | 6.753 M | 5.253 M | 5.755 M | 8.588 M | 9.487 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 580.833 M | 531.029 M | 514.321 M | 464.105 M | 541.953 M | 504.650 M | 499.153 M | 440.347 M | |
| Total liabilities | 115.419 M | 116.284 M | 153.641 M | 146.632 M | 142.036 M | 144.188 M | 150.056 M | 145.947 M | |
| Total current liabilities | 36.421 M | 42.289 M | 60.110 M | 57.155 M | 54.513 M | 58.603 M | 63.217 M | 66.487 M | |
| Accounts Payable | 6.169 M | 6.836 M | 9.511 M | 9.047 M | 8.066 M | 10.411 M | 8.269 M | 7.966 M | |
| Other liabilities | 68.888 M | 64.667 M | 60.667 M | 60.667 M | 60.667 M | 60.667 M | 62.467 M | 57.677 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 68.888 M | 64.667 M | 60.667 M | 60.667 M | 60.667 M | 60.667 M | 62.467 M | 57.677 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 465.414 M | 414.745 M | 360.680 M | 317.473 M | 399.917 M | 360.462 M | 349.097 M | 294.400 M | |
| Common stock | 68.641 M | 68.736 M | 68.797 M | 68.924 M | 71.377 M | 81.648 M | 81.913 M | 81.939 M | |
| Retained earnings | -961.667 M | -1.017 B | -1.078 B | -1.127 B | -1.167 B | -1.212 B | -1.231 B | -1.293 B |